Terms: = Cervical cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
31 results:
1. Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and
Palafox-Mariscal LA; Ortiz-Lazareno PC; Jave-Suárez LF; Aguilar-Lemarroy A; Villaseñor-García MM; Cruz-Lozano JR; González-Martínez KL; Méndez-Clemente AS; Bravo-Cuellar A; Hernández-Flores G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445768
[TBL] [Abstract] [Full Text] [Related]
2. ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in cervical cancer.
Li QS; Zheng PS
Cancer Res; 2023 Sep; 83(18):3095-3114. PubMed ID: 37350664
[TBL] [Abstract] [Full Text] [Related]
3. Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/smad2/3 signaling.
Shen L; Li Y; Hu G; Song X; Wang X; Li X; Xu X
Funct Integr Genomics; 2023 Apr; 23(2):133. PubMed ID: 37081108
[TBL] [Abstract] [Full Text] [Related]
4. LY6K depletion modulates TGF-β and EGF signaling.
Park S; Park D; Han S; Chung GE; Soh S; Ka HI; Joo HJ; Yang Y
Cancer Med; 2023 Jun; 12(11):12593-12607. PubMed ID: 37076981
[TBL] [Abstract] [Full Text] [Related]
5. TGF-β signaling promotes cervical cancer metastasis via CDR1as.
Zhong G; Zhao Q; Chen Z; Yao T
Mol Cancer; 2023 Mar; 22(1):66. PubMed ID: 37004067
[TBL] [Abstract] [Full Text] [Related]
6. KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through smad2.
Pan W; Wang S; Liu X; Wang M; Han X; Tian X; Lin J; Qiao X; Wang X
Exp Cell Res; 2023 Feb; 423(1):113458. PubMed ID: 36608837
[TBL] [Abstract] [Full Text] [Related]
7. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of cervical cancer via the TGF-β1/smad2/3 Pathway.
Liu P; Pei JJ; Li L; Li JW; Ke XP
Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
[TBL] [Abstract] [Full Text] [Related]
8. SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic cervical cancer: A Clinical Expansion Cohort of a Phase I Study.
Feng J; Tang D; Wang J; Zhou Q; Peng J; Lou H; Sun Y; Cai Y; Chen H; Yang J; Liu P; Wang L; Zou J
Clin Cancer Res; 2022 Dec; 28(24):5297-5305. PubMed ID: 35653122
[TBL] [Abstract] [Full Text] [Related]
9. Overexpressed miR-375-Loaded Restrains Development of cervical cancer Through Down-Regulation of Frizzled Class Receptor 4 (FZD4) with Liposome Nanoparticle as a Carrier.
Wang S; Xu L; Zhang Z; Wang P; Zhang R; He H; Chen L
J Biomed Nanotechnol; 2021 Sep; 17(9):1882-1889. PubMed ID: 34688334
[TBL] [Abstract] [Full Text] [Related]
10. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA Biomarkers of High-Grade cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract] [Full Text] [Related]
12. GDF15 knockdown suppresses cervical cancer cell migration in vitro through the TGF-β/smad2/3/Snail1 pathway.
Li L; Zhang R; Yang H; Zhang D; Liu J; Li J; Guo B
FEBS Open Bio; 2020 Dec; 10(12):2750-2760. PubMed ID: 33098235
[TBL] [Abstract] [Full Text] [Related]
13. smad2 rs4940086 heterozygosity increases the risk of cervical cancer development among the women in Bangladesh.
Haque PS; Apu MNH; Nahid NA; Islam F; Islam MR; Hasnat A; Islam MS
Mol Biol Rep; 2020 Jul; 47(7):5033-5040. PubMed ID: 32507921
[TBL] [Abstract] [Full Text] [Related]
14. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the smad2 Gene in Human cervical cancer Tissue and Cell Lines.
Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
[TBL] [Abstract] [Full Text] [Related]
15. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
Zhu L; Yu CL; Zheng Y
Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
[TBL] [Abstract] [Full Text] [Related]
16. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic cancers.
Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
[No Abstract] [Full Text] [Related]
17. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
Goto M; Osada S; Imagawa M; Nishizuka M
Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
[TBL] [Abstract] [Full Text] [Related]
18. miR-212/132 downregulates smad2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
Zhao JL; Zhang L; Guo X; Wang JH; Zhou W; Liu M; Li X; Tang H
IUBMB Life; 2015 May; 67(5):380-94. PubMed ID: 25988335
[TBL] [Abstract] [Full Text] [Related]
19. Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanism.
Zhang L; Hao Q; Bao L; Liu W; Fu X; Chen Y; Wu H
Mol Med Rep; 2014 Nov; 10(5):2675-80. PubMed ID: 25215638
[TBL] [Abstract] [Full Text] [Related]
20. SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.
Liu D; Li L; Zhang XX; Wan DY; Xi BX; Hu Z; Ding WC; Zhu D; Wang XL; Wang W; Feng ZH; Wang H; Ma D; Gao QL
Cancer Res; 2014 Oct; 74(19):5597-607. PubMed ID: 25142796
[TBL] [Abstract] [Full Text] [Related]
[Next]
